Skip to content

Citius Oncology, Inc. CTOR Cash Flow Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
-$26.61M-381%-$5.53M-10.8%-$5M+7.0%-$5.37M+30.6%-$7.74M-16.2%
$3.53M-10.9%$3.96M+72.1%$2.3M+8.1%$2.13M+1.8%$2.09M+15.5%
-$3.83M+47.9%-$7.35M-436%-$1.37M0.0%-$1.37M0.0%-$1.37M0.0%
-$600K+86.4%-$4.4M-206%-$1.44M0.0%-$1.44M0.0%-$1.44M0.0%
$20M
$15.13M+299%$3.79M0.0%$3.79M0.0%$3.79M0.0%
-$4.66M-238%$3.37M+244%$981.2K0.0%$981.2K0.0%$981.2K0.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Citius Oncology, Inc. generate?
Citius Oncology, Inc. (CTOR) generated -$13.9M in operating cash flow over the trailing twelve months.
Where does Citius Oncology, Inc.'s cash flow data come from?
Every line is extracted from Citius Oncology, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.